IL-23/IL-23R: Potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma

International Journal of Colorectal Disease

Volumn 26, Issue 12, 2011, Pages 1511-1518

  Lan, Feng ^a   Zhang, Le ^a   Wu, Junchao ^a   Zhang, Jie ^a   Zhang, Sen ^a   Li, Kai ^a   Qi, Yanyu ^a   Lin, Ping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Forkhead box P3; IL 23; IL 23 receptor; Intestinal polyp

Indexed keywords

INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CANCER GROWTH; CARCINOMA CELL; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTESTINE POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TISSUE LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

ADENOMATOUS POLYPS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-23 SUBUNIT P19; RECEPTORS, INTERLEUKIN; TRANSCRIPTION, GENETIC;

EID: 83655201522     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-011-1232-6     Document Type: Article

References (27)

1. B Oppmann R Lesley B Blom, et al. 2000 Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 13 715 725 10.1016/s1074-7613(00)00070-4 11114383 10.1016/S1074-7613(00)00070-4 1:CAS:528:DC%2BD3cXovV2ht7c%3D
2. C Parham M Chirica J Timans, et al. 2002 A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R J Immunol 168 5699 5708 12023369 1:CAS:528:DC%2BD38XktFCrtrw%3D (Pubitemid 34556153)
3. CS Lankford DM Frucht 2003 A unique role for IL-23 in promoting cellular immunity J Leukoc Biol 73 49 56 10.1189/jlb.0602326 12525561 10.1189/jlb.0602326 1:CAS:528:DC%2BD3sXnvVyitQ%3D%3D (Pubitemid 36125674)
4. JL Langowski X Zhang L Wu, et al. 2006 IL-23 promotes tumour incidence and growth Nature. 442 461 465 10.1038/nature04808 16688182 10.1038/nature04808 1:CAS:528:DC%2BD28XnsVajtbk%3D (Pubitemid 44264796)
5. S Wei I Kryczek W Zou 2006 Regulatory T-cell compartmentalization and trafficking Blood 108 426 431 10.1182/blood-2006-01-0177 16537800 10.1182/blood-2006-01-0177 1:CAS:528:DC%2BD28XntFehtrY%3D (Pubitemid 44061338)
6. PJ Coffer BM Burgering 2004 Forkhead-box transcription factors and their role in the immune system Nat Rev Immunol 4 889 899 10.1038/nri1488 15516968 10.1038/nri1488 1:CAS:528:DC%2BD2cXptFegtbw%3D (Pubitemid 39490764)
7. H Yagi T Nomura K Nakamura, et al. 2004 Crucial role of foxp3 in the development and function of human CD25∈+∈CD4∈+∈regulatory T cells Int Immunol 16 1643 1656 10.1093/intim/dxh165 15466453 10.1093/intimm/dxh165 1:CAS:528:DC%2BD2cXos1WqtbY%3D
8. M Beyer JL Schultze 2006 Regulatory T cells in cancer Blood 108 804 811 10.1182/blood -2006-02-002774 16861339 10.1182/blood-2006-02-002774 1:CAS:528:DC%2BD28XnvFajtrs%3D (Pubitemid 44154611)
9. N Stanilov L Miteva N Mintchev S Stanilova 2009 High expression of Foxp3, IL-23p19 and surviving mRNA in colorectal carcinoma Int J Colorectal Dis 24 151 157 10.1007/s00384-008-0588-8 18825388 10.1007/s00384-008-0588-8
10. + T regulatory cells show strong prognostic significance in colorectal cancer J Clin Oncol 27 186 192 10.1200/jco.2008.18.7229 19064967 10.1200/JCO.2008.18.7229
11. +) T-cell ratio predicts a clinical outcome of human colon carcinoma Gastroenterology 137 1270 1279 10.1053/j.gastro.2009.06.053 19577568 10.1053/j.gastro.2009.06.053 1:CAS:528:DC%2BD1MXht12gtr%2FP
12. +) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients Int J Cancer 126 2635 2643 10.1002/ijc.24989 19856313 1:CAS:528:DC%2BC3cXjvFKlsLk%3D
13. MM Center A Jemal RA Smith E Ward 2009 Worldwide variations in colorectal cancer CA Cancer J Clin 59 366 378 10.3322/caac.20038 19897840 10.3322/caac.20038
14. M Malvicini M Rizzo L Alaniz, et al. 2009 A novel synergistic combination of cyclophosphamide and gene transfer of interleukin-12 eradicates colorectal carcinoma in mice Clin. Cancer Res 15 7256 7265 10.1158/1078-0432.ccr-09-1861 19920110 10.1158/1078-0432.CCR-09-1861 1:CAS:528:DC%2BD1MXhsFSnu73O
15. M Fukuda M Ehara S Suzuki Y Ohmori H Sakashita 2010 IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity Int J Oncol 36 1355 1365 10.3892/ijo-00000620 20428758 10.3892/ijo-00000620 1:CAS:528:DC%2BC3cXnsVOqtLc%3D
16. M Kortylewski H Xin M Kujawski, et al. 2009 Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment Cancer Cell 15 114 123 10.1016/j.ccr.2008.12.018 19185846 10.1016/j.ccr.2008.12.018 1:CAS:528:DC%2BD1MXltFSmtLg%3D
17. EL Jared RT Troy AS Lisa, et al. 2006 Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor J Immunol 177 3133 3142
18. B Estelle D Maryam O Mohamed 2005 Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells Proc Natl Acad Sci USA 102 5138 5143 10.1073/pnas. 0501675102 10.1073/pnas.0501675102
19. PA Philip S Chris B Sofia, et al. 2010 Interleukin-23 drives intestinal inflammation through direct activity on T cells Immunity 33 279 288 10.1016/j.immuni. 2010.08.010 10.1016/j.immuni.2010.08.010
20. DJ Jung DH Jin SW Hong, et al. 2010 Foxp3 expression in p53-dependent DNA damage responses J Biol Chem 285 7995 8002 10.1074/jbc.M109.047985 20075077 10.1074/jbc.M109.047985 1:CAS:528:DC%2BC3cXislyqtb0%3D
21. CO Elson Y Cong CT Weaver TR Schoeb McClanah an TK RB Fick RA Kastelein 2007 Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice Gastroentryology 13 2359 2370 10.1053/j.gastro.2007.03.104 10.1053/j.gastro.2007.03.104 (Pubitemid 46890867)
22. S Hue P Ahern S Buonocore, et al. 2006 Interleukin-23 drives innate and T cell-mediated intestinal inflammation J Exp Med 203 2473 2483 10.1084/jem.20061099 17030949 10.1084/jem.20061099 1:CAS:528:DC%2BD28XhtFGqtL7I (Pubitemid 44664617)
23. MC Kullberg D Jankovic CG Feng, et al. 2006 IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis J Exp Med 203 2485 2494 10.1084/jem.20061082 17030948 10.1084/jem.20061082 1:CAS:528:DC%2BD28XhtFGqtL7J (Pubitemid 44664618)
24. D Yen J Cheung H Scheerens, et al. 2006 IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 J Clin Invest 116 1310 1316 10.1172/JCI21404 16670770 10.1172/JCI21404 1:CAS:528: DC%2BD28XksVWns78%3D
25. NF Che Mat X Zhang C Guzzo K Gee 2010 Interleukin-23-induced interleukin-23 receptor subunit expression is mediated by the Janus Kinase/signal transducer and activation of transcription pathway in human CD4 T cells J Interferon Cytokine Res 10.1089/jir.2010.0083 21138378
26. JR Chan W Blumenschein E Murphy, et al. 2006 IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis J Exp Med 203 2577 2587 10.1084/jem.20060244 17074928 10.1084/jem.20060244 1:CAS:528:DC%2BD28Xht12htLbL (Pubitemid 44833335)
27. T Kaiga M Sato H Kaneda 2007 Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12 J Immunol 178 7571 7758 17548592 1:CAS:528:DC%2BD2sXmtVKgtbg%3D